Pfizer and BioNTech Claim, Omicron Booster Is Stronger , Than Original Shot.<br />The companies made the claim via <br />a press release issued on Nov. 4.<br />Based on two company-led studies, the results have <br />not been confirmed by independent scientists.<br />Pfizer and BioNTech claim the results show their booster vaccine can be up to four times more effective for adults over 55.<br />As we head into the holiday season, we hope these updated data will encourage people to seek out a COVID-19 bivalent booster as soon as they <br />are eligible... , Albert Bourla, Pfizer Chairman and CEO, <br />via Pfizer Press Release.<br />... in order to maintain high levels of protection against the widely circulating Omicron BA.4 and BA.5 sublineages, Albert Bourla, Pfizer Chairman and CEO, <br />via Pfizer Press Release.<br />These updated data also provide confidence in the adaptability of our mRNA platform... , Albert Bourla, Pfizer Chairman and CEO, <br />via Pfizer Press Release.<br />... and our ability to rapidly update the vaccine to match the most prevalent strains <br />each season, Albert Bourla, Pfizer Chairman and CEO, <br />via Pfizer Press Release.<br />BioNTech's CEO stated that the companies will continue to tailor their vaccines to new COVID variants and subvariants.<br />In the next step and as part of our science-based approach we will continue to evaluate the cross-neutralization of the adapted vaccine against new variants and sublineages. , Professor Ugur Sahin, BioNTech CEO and Co-founder, via Pfizer Press Release.<br />Our goal is to provide broader immunity against COVID-19 caused by SARS-CoV-2, including Omicron and other <br />circulating strains, Professor Ugur Sahin, BioNTech CEO and Co-founder, via Pfizer Press Release.<br />According to the Pfizer press release, .<br />... the company has shared its data with <br />both the U.S. Food and Drug Administration <br />and the European Medicines Agency
